Skip to main content

Peer Review reports

From: Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study

Original Submission
13 Dec 2023 Submitted Original manuscript
16 Jan 2024 Reviewed Reviewer Report
24 Jan 2024 Reviewed Reviewer Report
5 Feb 2024 Reviewed Reviewer Report
5 Mar 2024 Author responded Author comments - Charles Argoff
20 Mar 2024 Reviewed Reviewer Report
21 Mar 2024 Reviewed Reviewer Report
25 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 2
5 Mar 2024 Submitted Manuscript version 2
Publishing
3 Apr 2024 Editorially accepted
25 Apr 2024 Article published 10.1186/s10194-024-01764-9

You can find further information about peer review here.

Back to article page